[Has the intermittent therapy of pulmonary tuberculosis a future in industrialised countries?].
D000818:Animals; D000995:Antitubercular Agents / Q000008:administration & dosage*; D001530:Belgium; D003223:Congo; D004338:Drug Combinations; D004977:Ethambutol / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D008297:Male; D008722:Methods; D051379:Mice; D012293:Rifampin / Q000008:administration & dosage; D013307:Streptomycin / Q000008:administration & dosage; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D004338:Drug Combinations; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
Hat die intermittierende Therapie der Lungen-tuberkulose eine Zukunft in den Industrieländern.